Home
Mercati
Grafici & Idee
Algo
Notizie
Store
Broker
Scarica
Calendario Economico
Segnali di Trading
Terminale Web
Digita
/
per cercare: @user, $symbol
Cerca
Accedi
Crea un account
日本語
English
Русский
中文
Español
Português
Deutsch
한국어
Français
Italiano
Türkçe
CCCC
#2959
C4 Therapeutics, Inc.
2.7
0
-1.46%
Settore:
Base:
Valuta di Profitto:
Intervallo Giornaliero
Intervallo Annuale
Variazione giornaliera
-1.46%
Variazione Mensile
+26.17%
Variazione di 6 mesi
+5.06%
Variazione Annuale
+4.25%
Chiusura Precedente
2.7
4
Open
2.7
0
Bid
Ask
Low
2.7
0
High
2.7
0
Volume
57
Mercati
Mercato Azionario Statunitense
Salute
CCCC
Open full chart
Financials
Overview
Estratto Conto
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Dividends per share
—
—
—
—
—
—
—
Dividend yield %
—
—
—
—
—
—
—
Payout ratio %
—
—
—
—
—
—
—
Notizie
Barclaysが臨床試験の進展を受けてC4 Therapeuticsの目標株価を引き上げ
Barclays raises C4 Therapeutics stock price target on trial progress
TD Cowen、C4 Therapeuticsに対する買い推奨を継続
TD Cowen reiterates Buy rating on C4 Therapeutics stock
【決算速報】C4 セラピューティクス、売上高は予想を上回り、利益は予想を上回る結果に
C4 earnings beat by $0.11, revenue topped estimates
ブルックライン・キャピタル、治験進展を受けC4 Therapeutics株の目標株価を引き上げ
Brookline Capital raises C4 Therapeutics stock price target on trial progress
C4 Therapeutics doses first patient in phase 2 myeloma trial
C4セラピューティクスのレイノ最高医療責任者、2.22万ドル相当の株式を売却
C4 Therapeutics’ chief medical officer Reyno sells $22,200 in stock
C4セラピューティクス、多発性骨髄腫向けセムシドミド臨床試験を推進へ